Literature DB >> 9054774

The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals.

N H Miller1, M Hill, T Kottke, I S Ockene.   

Abstract

Despite the universally accepted importance of compliance, strategies known for more than two decades to be effective are not routinely incorporated into clinical practice. For the benefits of primary and secondary prevention to be realized in diverse population groups and settings, emphasis must be placed on implementing strategies at the patient, provider, and organization levels. Current knowledge of compliance strategies, if integrated into a multilevel approach, offers enormous promise for decreasing risk and improving patient outcomes.

Entities:  

Mesh:

Year:  1997        PMID: 9054774     DOI: 10.1161/01.cir.95.4.1085

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  85 in total

Review 1.  Effect of partial compliance on cardiovascular medication effectiveness.

Authors:  Joyce A Cramer
Journal:  Heart       Date:  2002-08       Impact factor: 5.994

Review 2.  Nonpharmacologic options for the management of heart failure.

Authors:  Robin J Trupp; William T Abraham
Journal:  Curr Cardiol Rep       Date:  2003-05       Impact factor: 2.931

3.  Perceptions around concordance--focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners.

Authors:  Jasmina Bajramovic; Lynne Emmerton; Susan E Tett
Journal:  Health Expect       Date:  2004-09       Impact factor: 3.377

4.  The break-even point: when medical advances are less important than improving the fidelity with which they are delivered.

Authors:  Steven H Woolf; Robert E Johnson
Journal:  Ann Fam Med       Date:  2005 Nov-Dec       Impact factor: 5.166

Review 5.  A meta-analysis of the association between adherence to drug therapy and mortality.

Authors:  Scot H Simpson; Dean T Eurich; Sumit R Majumdar; Rajdeep S Padwal; Ross T Tsuyuki; Janice Varney; Jeffrey A Johnson
Journal:  BMJ       Date:  2006-06-21

Review 6.  Drug adherence in patients taking oral anticoagulation therapy.

Authors:  Sebastian Ewen; Volker Rettig-Ewen; Felix Mahfoud; Michael Böhm; Ulrich Laufs
Journal:  Clin Res Cardiol       Date:  2013-09-03       Impact factor: 5.460

7.  Patient Perceptions on Facilitating Follow-Up After Heart Failure Hospitalization.

Authors:  Khadijah Breathett; Rachel D'Amico; T M Ayodele Adesanya; Stefanie Hatfield; Shannon Willis; Rodney X Sturdivant; Randi E Foraker; Sakima Smith; Philip Binkley; William T Abraham; Pamela N Peterson
Journal:  Circ Heart Fail       Date:  2017-06       Impact factor: 8.790

8.  Description of pharmacist interventions during physician-pharmacist co-management of hypertension.

Authors:  Shannon J Von Muenster; Barry L Carter; Cynthia A Weber; Michael E Ernst; Jessica L Milchak; Jennifer J G Steffensmeier; Yinghui Xu
Journal:  Pharm World Sci       Date:  2007-08-21

9.  Effects of an enhanced secondary prevention program for patients with heart disease: a prospective randomized trial.

Authors:  Steven M Edworthy; Bonnie Baptie; Donna Galvin; Rollin F Brant; Terry Churchill-Smith; Dante Manyari; Israel Belenkie
Journal:  Can J Cardiol       Date:  2007-11       Impact factor: 5.223

10.  A comparison of carotid surgery in northern Europe and northern Africa.

Authors:  Ashraf G Taha; Pirkka Vikatmaa; Lauri Soinne; Bahgat A Thabet; Mauri Lepäntalo
Journal:  World J Surg       Date:  2010-02       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.